SK Capital Partners Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
40

- Investments
-
97
- Portfolio
-
27
- Exits
-
20

SK Capital Partners General Information
Company Description
Founded in 2007, SK Capital Partners is a private equity firm based in New York, New York. The firm prefers to invest in companies operating in the specialty materials, ingredients, and life sciences sectors. This firm is a Registered Investment Adviser (RIA). The firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. The firm aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher-performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. The firm's portfolio of businesses generates revenues of approximately $10 billion annually, employs more than 25,000 people globally, and operates more than 200 plants in over 30 countries. The Firm currently has approximately $10 billion in assets under management.
Business Details
Website
www.skcapitalpartners.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 430 Park Avenue
- 18th Floor
- New York, NY 10022
- United States
SK Capital Partners Investments & Acquisitions (97)
SK Capital Partners’s most recent investment was a
with LISI Medical. The deal was made on 09-Jul-2025 with as the lead partner.Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
LISI Medical | 09-Jul-2025 | Medical Supplies | Generating Revenue | |||
Bluebird Bio | 02-Jun-2025 | Biotechnology | Generating Revenue/Not Profitable | |||
Spectrum Vascular | 26-Mar-2025 | Other Devices and Supplies | Generating Revenue | |||
PPT Group | 04-Mar-2025 | Machinery (B2B) | Profitable | |||
Colors for Plastics | 31-Jan-2025 | Buyout/LBO | Metal Containers and Packaging | Generating Revenue |
SK Capital Partners Exits (20)
SK Capital Partners has made a total of 20 exits. Its latest exit was from Ascend Performance Materials for on 21-Apr-2025. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ascend Performance Materials | 21-Apr-2025 | ||
Florachem | 09-Apr-2025 | ||
Foremark Performance Chemicals | 24-Apr-2024 | ||
Heubach | 22-Apr-2024 | ||
Ipackchem Group | 26-Mar-2024 | Merger/Acquisition |
SK Capital Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
SK Capital Partners Investments by Industry, Year, and Region
SK Capital Partners FAQs
-
What is SK Capital Partners?
Founded in 2007, SK Capital Partners is a private equity firm based in New York, New York.
-
When was SK Capital Partners founded?
SK Capital Partners was founded in 2007.
-
Where is SK Capital Partners headquartered?
SK Capital Partners is headquartered in New York, NY.
-
What is SK Capital Partners's total asset value?
SK Capital Partners has around
in total assets under management. -
How many investments has SK Capital Partners made?
SK Capital Partners has made 97 investments.
-
What has SK Capital Partners invested in?
SK Capital Partners has made numerous investments in companies like LISI Medical, Bluebird Bio, and Spectrum Vascular within the Medical Supplies, Biotechnology, and Devices and Supplies industries.
-
What has SK Capital Partners invested in recently?
SK Capital Partners's latest investment was on 09-Jul-2025 in LISI Medical, a company within the Medical Supplies industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »